As i understand it from those that analyzed the possible panels, the odds of getting these three was slim yet there they were. Conspiracy anybody? fix anybody?
JL - I hear you on EU. We're good there. But, I don't see how to stop the generics in the US. The whole system is rigged in their favor. (PS. I'm terrified for America, she may be done if certain events unfold).
Medical Research Collab is suggesting hikma or another generic company could do Marine like trials and apply to EMA for a marketing license for the hyperlipidemia indication and not violate the 10 year marketing exclusivity granted to Vascepa as a new active substance for the Reduce-It indication. When I look at the rules, I don't see that as possible. Your thoughts?
News 
Market Data 
Discover 
